Shilpa Medicare Ltd 2024 AR2

The report highlights Shilpa Medicare Limited's financial and operational achievements for the fiscal year 2023-24, including a revenue increase to ‑1,15,977 Lakhs. The company expanded its global reach in oncology and non-oncology APIs, formulations, and biosimilars, launching its first biological product, High Concentration Adalimumab, in India. On the ESG front, the company demonstrated environmental stewardship by sourcing 88.3% of its energy needs from renewable sources and recycling 100% of wastewater through zero liquid discharge systems. Additionally, the company advanced its social commitment through extensive CSR initiatives in education, healthcare, and community development.

Company: Shilpa Medicare Ltd

Sector: Health Care

Country: India

Year: 2024

Type: AR2

Pages: 288

Back to company

Shilpa Medicare Ltd

Shilpa Medicare Ltd 2024 Annual Report

Annual Report

The report highlights Shilpa Medicare Limited's financial and operational achievements for the fiscal year 2023-24, including a revenue increase to ‑1,15,977 Lakhs. The company expanded its global reach in oncology and non-oncology APIs, formulations, and biosimilars, launching its first biological product, High Concentration Adalimumab, in India. On the ESG front, the company demonstrated environmental stewardship by sourcing 88.3% of its energy needs from renewable sources and recycling 100% of wastewater through zero liquid discharge systems. Additionally, the company advanced its social commitment through extensive CSR initiatives in education, healthcare, and community development.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Apr 1, 2023 - Mar 31, 2024

Fiscal Year

2024

Published

Aug 26, 2024

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Net Zero Target

Employees